Skip to content
Legislation establishing clear rules about the kinds of ideas that can be patented would support innovation in biotech and other fields by eliminating ambiguities […]
Senators seek patent clarity to support innovation Read More »
European countries don’t just pull prices for medicines out of thin air. The prices that those governments set are based on specific sets of
It is often taken as a given that drug prices in the U.S. are higher than those in other nations. And while there is
Putting Americans First: International prices in context Read More »
The most notable differences between the pharmaceutical market in the U.S. and those in other countries are not in the prices. They’re in the
It has been three years since the Inflation Reduction Act (IRA) was signed into law. “We have definitively seen negative impacts on patient access,
BIO Coffee Chat looks at patient access after three years of the IRA Read More »
Over 8 million people in the U.S., and 125 million worldwide, live with psoriasis—about 2–3% of the population. Far from being a simple cosmetic
Psoriasis awareness: The condition is more than skin deep Read More »
As drug makers work to develop safe, effective gene therapies, their progress can be slowed when they challenge the limits of established regulatory guidance
The federal government’s program that provides seed funding to support research by biotech startups provides much more than money, said program officials and small
BIO 2025: Federal seed funding also comes with valuable advice Read More »
Litigation opposing drug price controls in the Inflation Reduction Act (IRA) has yet to have a major impact, but the cases are still ongoing
BIO 2025: Legal experts break down cases against IRA price controls Read More »
Given the essential role that intellectual property plays in the development of lifesaving scientific advances, we need to defend and strengthen policy that protects
Protect IP protections, BIO 2025 panel urges Read More »
